Compound ID | 836
Class: Oxazolidinone
| Spectrum of activity: | Gram-negative |
| Description: | Hackbarth CJ, Gomez M, Asano, RL, et al. In vitro activity of new oxazolidinones against anaerobic bacteria. 43rd-ICAAC 2003;262 |
| Institute where first reported: | Vicuron Pharmaceuticals (Pfizer, USA) |
| Year first mentioned: | 2003 |
| Highest developmental phase: | Preclinical |
| Development status: | Inactive |
| External links: | |
| Citation: |